A new employee of a large city hospital suffered from a lung disease for which there were no approved drug treatments. The employee had been taking Actimmune for years, with an annual cost of $1,248,000/year.
PBIRx® explored various savings options and determined that securing 340B pricing would lower the costs dramatically to $1.56 per year!
To do so required finding and liaising with the member’s primary care physician and pulmonologist; communicating key pieces of information to all necessary parties; confirming 340B eligibility; orchestrating drug availability at the hospital’s employee pharmacy and overseeing record management and compliance.
PBIRx succeeded on all fronts in not only lowering plan costs but also ensuring that all plan members would be able to access needed medications at lower costs.